Asociacion entre la infeccion por el virus linfocitotropico tipo I (HTLV-I) y la paraparesia espastica del Pacifico

Zaninovic M., Vladimir; Arango, Cesar; Biojo, Robin; Ramirez, Hernan; Borrero, Isabella.
Colomb. med ; 17(2): 101-3, 1986. tab
Artículo en Español | LILACS | ID: lil-81497

Documentos relacionados

  1. Precise excision of HTLV-1 provirus with a designer-recombinase.
  2. Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
  3. Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
  4. Patient research priority setting partnership in human T-cell lymphotropic virus type I.
  5. Novel insights into human T-lymphotropic virus type-1 (HTLV-1) pathogenesis-host interactions in the manifestation of HTLV-1-associated myelopathy/tropical spastic paraparesis.
  6. HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors.
  7. CD49d Is Upregulated in Circulating T Lymphocytes from HTLV-1-Infected Patients.
  8. Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis.
  9. Spirituality as Strategies for Coping With Tropical Spastic Paraparesis: Results of Focus Group.
  10. HTLV, a multi organ oncovirus.